Genistein sensitizes sarcoma cells in vitro and in vivo by enhancing apoptosis and by inhibiting DSB repair pathways

Por Liu, X.X., Sun, C., Jin, X.D., Li, P., Zheng, X.G., Zhao, T., Li, Q.
Publicado no J Radiat Res (2016)

T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

Por Turka, L A, Linsley, P S, Lin, H, Brady, W, Leiden, J M, Wei, R Q, Gibson, M L, Zheng, X G, Myrdal, S, Gordon, D
Publicado em 1992